Formuepleje A/S’s Amedisys AMED Stock Holding History

Formuepleje A/S’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53,638	Closed	-$5.19M	–	81
2022 Q3	$5.19M	Buy	+53,638	New	+$6.4M	0.42%	57

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Formuepleje A/S's AMED Position: Q4 2022 in Review

Formuepleje A/S sold out of Amedisys (AMED) in Q4 2022, closing a stake of 53,638 shares — an estimated $5.19M sold.

Formuepleje A/S first reported a position in AMED in Q3 2022 and held it in 1 quarter. The position peaked at $5.19M in Q3 2022. 276 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

Formuepleje A/S reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
Formuepleje A/S sold 53,638 Amedisys shares in Q4 2022, an estimated $5.19M.
Formuepleje A/S first reported a position in Amedisys in Q3 2022 and held it in 1 quarter.
Formuepleje A/S's Amedisys position peaked at $5.19M in Q3 2022.
276 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Formuepleje A/S's 13F filing for Q4 2022, filed 27 Aug 2026.